Disease Burden and Etiologic Distribution of Community-Acquired Pneumonia in Adults: Evolving Epidemiology in the Era of Pneumococcal Conjugate Vaccines

키워드

참고문헌 (75)

1. Choi MJ, "Disease burden of hospitalized community-acquired pneumonia in South Korea: Analysis based on age and underlying medical conditions", Medicine (Baltimore), 96, pp.e8429~ (2017)
2. Heo JY, "Incidence and case fatality rates of community-acquired pneumonia and pneumococcal diseases among Korean adults: Catchment population-based analysis", PLoS One, 13, pp.e0194598~ (2018)
3. American Thoracic Society, "Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia", Am J Respir Crit Care Med, 171, pp.388~416 (2005)
4. Kalil AC, "Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society", Clin Infect Dis, 63, pp.e61~e111 (2016)
5. Jeong BH, "Performances of prognostic scoring systems in patients with healthcare-associated pneumonia", Clin Infect Dis, 56, pp.625~632 (2013)
6. Kamata K, "Clinical evaluation of the need for carbapenems to treat community-acquired and healthcare-associated pneumonia", J Infect Chemother, 21, pp.596~603 (2015)
7. 고성주, "Clinical characteristics of nursing home-acquired pneumonia in elderly patients admitted to a Korean teaching hospital", The Korean Journal of Internal Medicine, 30(5), pp.638~647 (2015), 대한내과학회[DOI]
8. Kosai K, "Importance of functional assessment in the management of community-acquired and healthcare-associated pneumonia", Intern Med, 53, pp.1613~1620 (2014)
9. Maruyama T, "A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy", Clin Infect Dis, 57, pp.1373~1383 (2013)
10. Geno KA, "Pneumococcal Capsules and Their Types: Past, Present, and Future", Clin Microbiol Rev, 28, pp.871~899 (2015)
11. Bonten MJ, "Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults", N Engl J Med, 372, pp.1114~1125 (2015)
12. McLaughlin JM, "Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Hospitalization for Community-Acquired Pneumonia in Older US Adults: A Test-Negative Design", Clin Infect Dis, 67, pp.1498~1506 (2018)
13. Gil-Prieto R, "The burden of hospitalisations for community-acquired pneumonia (CAP) and pneumococcal pneumonia in adults in Spain (2003-2007)", Vaccine, 29, pp.412~416 (2011)
14. Griffin MR, "U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination", N Engl J Med, 369, pp.155~163 (2013)
15. Gutiérrez F, "Epidemiology of community-acquired pneumonia in adult patients at the dawn of the 21st century: a prospective study on the Mediterranean coast of Spain", Clin Microbiol Infect, 11, pp.788~800 (2005)
16. Jackson ML, "The burden of community-acquired pneumonia in seniors: results of a population-based study", Clin Infect Dis, 39, pp.1642~1650 (2004)
17. Jain S, "Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults", N Engl J Med, 373, pp.415~427 (2015)
18. Kaplan V, "Hospitalized community-acquired pneumonia in the elderly: age- and sex-related patterns of care and outcome in the United States", Am J Respir Crit Care Med, 165, pp.766~772 (2002)
19. Lovering AM, "Epidemiology and resource utilization for patients hospitalized for lower respiratory tract infection", Clin Microbiol Infect, 7, pp.666~670 (2001)
20. Millett ER, "Incidence of community-acquired lower respiratory tract infections and pneumonia among older adults in the United Kingdom: a population-based study", PLoS One, 8, pp.e75131~ (2013)
21. Monge V, "Hospital admissions for pneumonia in Spain", Infection, 29, pp.3~6 (2001)
22. Ochoa-Gondar O, "The burden of community-acquired pneumonia in the elderly: the Spanish EVAN-65 study", BMC Public Health, 8, pp.222~ (2008)
23. Ramirez JA, "Adults Hospitalized With Pneumonia in the United States: Incidence, Epidemiology, and Mortality", Clin Infect Dis, 65, pp.1806~1812 (2017)
24. Sicras-Mainar A, "Retrospective epidemiological study for the characterization of community- acquired pneumonia and pneumococcal pneumonia in adults in a well-defined area of Badalona (Barcelona, Spain)", BMC Infect Dis, 12, pp.283~ (2012)
25. Simonsen L, "Effect of 13-valent pneumococcal conjugate vaccine on admissions to hospital 2 years after its introduction in the USA: a time series analysis", Lancet Respir Med, 2, pp.387~394 (2014)
26. Fitzwater SP, "The worldwide impact of the seven-valent pneumococcal conjugate vaccine", Pediatr Infect Dis J, 31, pp.501~508 (2012)
27. Tsaban G, "Indirect (herd) protection, following pneumococcal conjugated vaccines introduction: A systematic review of the literature", Vaccine, 35, pp.2882~2891 (2017)
28. Lopardo GD, "Incidence rate of community-acquired pneumonia in adults: a population-based prospective active surveillance study in three cities in South America", BMJ Open, 8, pp.e019439~ (2018)
29. Morimoto K, "The burden and etiology of community-onset pneumonia in the aging Japanese population: a multicenter prospective study", PLoS One, 10, pp.e0122247~ (2015)
30. Schnoor M, "Approaches to estimate the population-based incidence of community acquired pneumonia", J Infect, 55, pp.233~239 (2007)
31. Simonsen L, "Impact of pneumococcal conjugate vaccination of infants on pneumonia and influenza hospitalization and mortality in all age groups in the United States", MBio, 2, pp.e00309~e00310 (2011)
32. Takaki M, "High incidence of community-acquired pneumonia among rapidly aging population in Japan: a prospective hospital-based surveillance", Jpn J Infect Dis, 67, pp.269~275 (2014)
33. Vila-Corcoles A, "Epidemiology of community-acquired pneumonia in older adults: a population-based study", Respir Med, 103, pp.309~316 (2009)
34. Grijalva CG, "Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis", Lancet, 369, pp.1179~1186 (2007)
35. Welte T, "Global and local epidemiology of community-acquired pneumonia: the experience of the CAPNETZ Network", Semin Respir Crit Care Med, 30, pp.127~135 (2009)
36. Welte T, "Clinical and economic burden of community-acquired pneumonia among adults in Europe", Thorax, 67, pp.71~79 (2012)
37. Arnold FW, "Mortality differences among hospitalized patients with community-acquired pneumonia in three world regions: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort Study", Respir Med, 107, pp.1101~1111 (2013)
38. Anevlavis S, "Community acquired bacterial pneumonia", Expert Opin Pharmacother, 11, pp.361~374 (2010)
39. Chung MH, "Etiology of communityacquired pneumonia surveyed by 7 university hospitals", Korean J Infect Dis, 29, pp.339~359 (1997)
40. 손장욱, "Atypical Pathogens as Etiologic Agents in Hospitalized Patients with Community-Acquired Pneumonia in Korea: A Prospective Multi-Center Study", Journal of Korean Medical Science, 21(4), pp.602~607 (2006), 대한의학회
41. Song JH, "Epidemiology and clinical outcomes of community-acquired pneumonia in adult patients in Asian countries: a prospective study by the Asian network for surveillance of resistant pathogens", Int J Antimicrob Agents, 31, pp.107~114 (2008)
42. Woo JH, "A prospective multicenter study of community-acquired pneumonia in adults with emphasis on bacterial etiology", Korean J Infect Dis, 33, pp.1~7 (2001)
43. Yu CW, "Clinical Features and Prognosis of Community-acquired Pneumonia in the Elderly Patients", Korean J Infect Dis, 32, pp.212~218 (2000)
44. Ahn JH, "Clinical characteristics and prognostic risk factors of healthcare-associated pneumonia in a Korean tertiary teaching hospital", Medicine (Baltimore), 96, pp.e8243~ (2017)
45. Kim ES, "Comparison of viral infection in healthcare-associated pneumonia (HCAP) and community-acquired pneumonia (CAP)", PLoS One, 13, pp.e0192893~ (2018)
46. 이홍열, "Intermediate risk of multidrug-resistant organisms in patients who admitted intensive care unit with healthcare-associated pneumonia", The Korean Journal of Internal Medicine, 31(3), pp.525~534 (2016), 대한내과학회
47. Seo H, "Relationship Between Clinical Features and Computed Tomographic Findings in Hospitalized Adult Patients With Community-Acquired Pneumonia", Am J Med Sci, 356, pp.30~38 (2018)
48. 이미숙, "Guideline for Antibiotic Use in Adults with Community-acquired Pneumonia", Infection and Chemotherapy, 50(2), pp.160~198 (2018), 대한감염학회
49. 강윤성, "Antimicrobial Resistance and Clinical Outcomes in Nursing Home-Acquired Pneumonia, Compared to Community-Acquired Pneumonia", Yonsei Medical Journal, 58(1), pp.180~186 (2017), 연세대학교의과대학[DOI]
50. Ladhani SN, "Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000-17: a prospective national observational cohort study", Lancet Infect Dis, 18, pp.441~451 (2018)
51. Pelton SI, "Decline in Pneumococcal Disease Attenuated in Older Adults and Those with Comorbidities Following Universal Childhood PCV13 Immunization", Clin Infect Dis (2018)
52. Choi MJ, "Clinical usefulness of pneumococcal urinary antigen test, stratified by disease severity and serotypes", J Infect Chemother, 21, pp.672~679 (2015)
53. 정용필, "지역사회획득 폐렴의 원인 미생물에 대한 전향적 다기관 연구: 세균성 폐렴의 원인균 분석", Infection and Chemotherapy, 42(6), pp.397~403 (2010), 대한감염학회
54. Eun Ju Jeon, "The Difference in Clinical Presentations between Healthcare-Associated and Community-Acquired Pneumonia in University-Affiliated Hospital in Korea", Yonsei Medical Journal, 52(2), pp.282~287 (2011), 연세대학교의과대학
55. 성명길, "Healthcare-Associated Pneumonia among Hospitalized Patients: Is It Different from Community Acquired Pneumonia?", Tuberculosis and Respiratory Diseases, 76(2), pp.66~74 (2014), 대한결핵및호흡기학회
56. 유광하, "Economic Burden and Epidemiology of Pneumonia in Korean Adults Aged over 50 Years", Journal of Korean Medical Science, 28(6), pp.888~895 (2013), 대한의학회
57. Pilishvili T, "Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine", J Infect Dis, 201, pp.32~41 (2010)
58. Klugman KP, "Herd protection induced by pneumococcal conjugate vaccine", Lancet Glob Health, 2, pp.e365~e366 (2014)
59. Kollef MH, "Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia", Chest, 128, pp.3854~3862 (2005)
60. Micek ST, "Health care-associated pneumonia and community-acquired pneumonia: a single-center experience", Antimicrob Agents Chemother, 51, pp.3568~3573 (2007)
61. Fukuyama H, "Validation of sputum Gram stain for treatment of community-acquired pneumonia and healthcare-associated pneumonia: a prospective observational study", BMC Infect Dis, 14, pp.534~ (2014)
62. Ishida T, "Clinical characteristics of nursing and healthcare-associated pneumonia: a Japanese variant of healthcare-associated pneumonia", Intern Med, 51, pp.2537~2544 (2012)
63. Parrott G, "Etiological analysis and epidemiological comparison among adult CAP and NHCAP patients in Okinawa, Japan", J Infect Chemother, 23, pp.452~458 (2017)
64. Polverino E, "Microbial aetiology of healthcare associated pneumonia in Spain: a prospective, multicentre, case-control study", Thorax, 68, pp.1007~1014 (2013)
65. Vallés J, "Epidemiology, antibiotic therapy and clinical outcomes of healthcare-associated pneumonia in critically ill patients: a Spanish cohort study", Intensive Care Med, 40, pp.572~581 (2014)
66. Chalmers JD, "Healthcare-associated pneumonia does not accurately identify potentially resistant pathogens: a systematic review and meta-analysis", Clin Infect Dis, 58, pp.330~339 (2014)
67. Chen JI, "Outcomes of health care-associated pneumonia empirically treated with guideline-concordant regimens versus community-acquired pneumonia guideline-concordant regimens for patients admitted to acute care wards from home", Ann Pharmacother, 47, pp.9~19 (2013)
68. Webb BJ, "Guideline-concordant antibiotic therapy and clinical outcomes in healthcare-associated pneumonia", Respir Med, 106, pp.1606~1612 (2012)
69. Grenier C, "Impact of guideline-consistent therapy on outcome of patients with healthcare-associated and community-acquired pneumonia", J Antimicrob Chemother, 66, pp.1617~1624 (2011)
70. 양태언, "Influenza and Pneumococcal Vaccine Coverage Rates among Patients Admitted to a Teaching Hospital in South Korea", Infection and Chemotherapy, 47(1), pp.41~48 (2015), 대한감염학회
71. Tan CG, "A preventable outbreak of pneumococcal pneumonia among unvaccinated nursing home residents in New Jersey during 2001", Infect Control Hosp Epidemiol, 24, pp.848~852 (2003)
72. Nuorti JP, "An outbreak of multidrug-resistant pneumococcal pneumonia and bacteremia among unvaccinated nursing home residents", N Engl J Med, 338, pp.1861~1868 (1998)
73. Baek JY, "Emergence of multidrug-resistant clones in levofloxacin-nonsusceptible Streptococcus pneumoniae isolates in Korea", Diagn Microbiol Infect Dis, 91, pp.287~290 (2018)
74. Choi MJ, "Spread of ceftriaxone non-susceptible pneumococci in South Korea: Long-term care facilities as a potential reservoir", PLoS One (2018)
75. Park M, "Novel Levofloxacin-Resistant Multidrug-Resistant Streptococcus pneumoniae Serotype 11A Isolates, South Korea", Emerg Infect Dis, 22, pp.1978~1980 (2016)

관련 논문AI추천